Prasugrel hydroxy thiolactone

• Description :

  Prasugrel hydroxy thiolactone (compound M18) is a metabolite of Prasugrel (HY-15284) . Prasugrel is an orally active and potent P2Y12 receptor antagonist, and inhibits Adenosine 5'-diphosphate (ADP, HY-W010918) -induced platelet aggregation[1].

• UNSPSC :

  12352005

• Hazard Statement :

  H302-H315-H319-H335

• Target :

  Drug Metabolite; P2Y Receptor

• Type :

  Reference compound

• Related Pathways :

  GPCR/G Protein; Metabolic Enzyme/Protease

• Applications :

  Neuroscience-Neuromodulation

• Field of Research :

  Cardiovascular Disease

• Assay Protocol :

  https://www.medchemexpress.com/prasugrel-hydroxy-thiolactone.html

• Smiles :

  OC12CCN(C(C3=CC=CC=C3F)C(C4CC4)=O)CC1=CC(S2)=O

• Molecular Formula :

  C18H18FNO3S

• Molecular Weight :

  347.40

• Precautions :

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations :

  [1]Smith RL, et al. Disposition and metabolic fate of prasugrel in mice, rats, and dogs. Xenobiotica. 2007 Aug;37 (8) :884-901.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [947502-66-1]